Instil Bio TIL
NASDAQ TIL
$7.34 +0.11 (+1.45%)
As of: Oct 2, 2026 · 1:10 PM EDT

Instil Bio (TIL) Price to Sales (2021)

Updated

Instil Bio's Price to Sales came in at 47833.02 for Q2 2021, up 412.6% from the prior quarter.

Analysis

Instil Bio (TIL) Price to Sales (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Instil Bio 49.10 Mn 49.10 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 47,833.02
Mar 31, 2021 9,332.07
API Access

Instil Bio Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=TIL&period=max&api_key=YOUR_API_KEY